Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Feniralstat

Copy Product Info
😃Good
Catalog No. T63507Cas No. 2166320-76-7
Alias KVD-824, KVD824

Feniralstat (KVD-824) is a selective and highly efficient kallikrein inhibitor. It can be used for researching immune system diseases and cardiovascular diseases.

Feniralstat

Feniralstat

Copy Product Info
😃Good
Purity: 99.52%
Catalog No. T63507Alias KVD-824, KVD824Cas No. 2166320-76-7
Feniralstat (KVD-824) is a selective and highly efficient kallikrein inhibitor. It can be used for researching immune system diseases and cardiovascular diseases.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$198-In Stock
5 mg$519-In Stock
10 mg$743-In Stock
25 mg$1,520-In Stock
50 mg$1,980-In Stock
1 mL x 10 mM (in DMSO)$590-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.52%
Appearance:Solid
Color:Gray
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Feniralstat (KVD-824) is a selective and highly efficient kallikrein inhibitor. It can be used for researching immune system diseases and cardiovascular diseases.
Targets&IC50
plasma kallikrein (pKal) (human):6.7 nM
In vitro
Feniralstat (Compound 30) is a pyrazole derivative that potently inhibits kallikrein with an IC50 of 6.7 nM for human plasma kallikrein (pKal).Feniralstat weakly inhibits human KLK1, human FXIa, and human Factor XIIa (all with IC50s above 40 μM). [1]
SynonymsKVD-824, KVD824
Chemical Properties
Molecular Weight509.51
FormulaC26H25F2N5O4
Cas No.2166320-76-7
SmilesO=C1C=CC(F)=CN1CC2=CC=C(C=C2)CN3N=C(C(=C3)C(=O)NCC4=NC=CC(OC)=C4F)COC
Storage & Solubility Information
Storagekeep away from direct sunlight,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 80 mg/mL (157.01 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (3.93 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.9627 mL9.8134 mL19.6267 mL98.1335 mL
5 mM0.3925 mL1.9627 mL3.9253 mL19.6267 mL
10 mM0.1963 mL0.9813 mL1.9627 mL9.8134 mL
20 mM0.0981 mL0.4907 mL0.9813 mL4.9067 mL
50 mM0.0393 mL0.1963 mL0.3925 mL1.9627 mL
100 mM0.0196 mL0.0981 mL0.1963 mL0.9813 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Feniralstat | purchase Feniralstat | Feniralstat cost | order Feniralstat | Feniralstat chemical structure | Feniralstat in vitro | Feniralstat formula | Feniralstat molecular weight